Research Article
Development and Validation of Stability Indicating RP-HPLC Method for Estimation of Satranidazole from Its Formulation
Table 3
Results of precision study.
| Replicates | Method precision Day-1 analyst-1 (% assay) | Intermediate precision Day-2 analyst-2 (% assay) |
| Assay-1 | 99.93 | 101.41 | Assay-2 | 101.26 | 100.28 | Assay-3 | 99.8 | 98.89 | Assay-4 | 101.73 | 99.22 | Assay-5 | 101.93 | 98.82 | Assay-6 | 98.4 | 101.81 |
| Average | 100.5083 | 100.0717 | Standard deviation (SD) | 1.3682 | 1.30726 | % relative standard deviation (% RSD) | 1.3612 | 1.3063 |
| Average | 100.29 | Standard deviation (SD) | 1.2960 | % relative standard deviation (% RSD) | 1.2923 |
|
|